These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6688157)

  • 21. Use of atracurium and vecuronium in patients with oesophageal varices.
    Bell CF; Hunter JM; Jones RS; Utting JE
    Br J Anaesth; 1985 Feb; 57(2):160-8. PubMed ID: 2857569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of atracurium and other non-depolarizing neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction.
    Miller RD
    Br J Anaesth; 1986; 58 Suppl 1():11S-13S. PubMed ID: 2871850
    [No Abstract]   [Full Text] [Related]  

  • 23. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anesthesia and the Lesch-Nyhan syndrome.
    Larson LO; Wilkins RG
    Anesthesiology; 1985 Aug; 63(2):197-9. PubMed ID: 3839638
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
    Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
    Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
    Martin-Flores M; Paré MD; Campoy L; Gleed RD
    Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atracurium in infants and children.
    Goudsouzian NG
    Br J Anaesth; 1986; 58 Suppl 1():23S-28S. PubMed ID: 3518764
    [No Abstract]   [Full Text] [Related]  

  • 28. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atracurium in the myasthenic patient.
    Bell CF; Florence AM; Hunter JM; Jones RS; Utting JE
    Anaesthesia; 1984 Oct; 39(10):961-8. PubMed ID: 6093617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromuscular effects of atracurium in man.
    Katz RL; Stirt J; Murray AL; Lee C
    Anesth Analg; 1982 Sep; 61(9):730-4. PubMed ID: 6285767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of atracurium during N2O/O2, fentanyl, and N2O/O2, enflurane anesthesia regimens.
    Ramsey FM; White PA; Stullken EH; Lineberry CG; Allen LL
    Anesthesiology; 1984 Sep; 61(3):328-31. PubMed ID: 6548097
    [No Abstract]   [Full Text] [Related]  

  • 32. Atracurium in the severely ill.
    Rowlands DE
    Br J Anaesth; 1983; 55 Suppl 1():123S-124S. PubMed ID: 6688005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromuscular blockade in dystrophia myotonica with atracurium besylate.
    Boheimer N; Harris JW; Ward S
    Anaesthesia; 1985 Sep; 40(9):872-4. PubMed ID: 3840335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atracurium in renal failure.
    Hunter JM; Jones RS; Utting JE
    Br J Anaesth; 1983; 55 Suppl 1():129S. PubMed ID: 6688007
    [No Abstract]   [Full Text] [Related]  

  • 35. Evoked electromyographic and mechanical responses of the adductor pollicis compared during the onset of neuromuscular blockade by atracurium or alcuronium, and during antagonism by neostigmine.
    Harper NJ; Bradshaw EG; Healy TE
    Br J Anaesth; 1986 Nov; 58(11):1278-84. PubMed ID: 3778792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.
    Savarese JJ; McGilvra JD; Sunaga H; Belmont MR; Van Ornum SG; Savard PM; Heerdt PM
    Anesthesiology; 2010 Jul; 113(1):58-73. PubMed ID: 20526187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory problems after atropine and neostigmine in dogs.
    Hall LW; Kellagher RE; Watkins SB
    Br J Anaesth; 1985 Oct; 57(10):1046. PubMed ID: 3840027
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.
    Basta SJ; Ali HH; Savarese JJ; Sunder N; Gionfriddo M; Cloutier G; Lineberry C; Cato AE
    Anesth Analg; 1982 Sep; 61(9):723-9. PubMed ID: 6213181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia.
    Ording H; Nielsen VG
    Br J Anaesth; 1986 Sep; 58(9):1001-4. PubMed ID: 3092848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function.
    Hunter JM; Jones RS; Utting JE
    Br J Anaesth; 1984 Sep; 56(9):941-51. PubMed ID: 6147153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.